A Longer Duration of Neo-Adjuvant Combined Androgen Blockade Prior to Radical Prostatectomy May Lead to Lower Tumour Volume of Localised Prostate Cancer

Author： Lorente J.A.   Arango O.   Bielsa O.   Cortadellas R.   Lloreta-Trull J.   Gelabert-Mas A.  

Publisher： Elsevier

ISSN： 0302-2838

Source： European Urology, Vol.43, Iss.2, 2003-02, pp. : 119-123

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prolonged neoadjuvant combined androgen blockade leads to a further reduction of prostatic tumor volume: three versus six months of endocrine therapy - a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer

By van der Kwast T.H.   Tetu B.   Candas B.   Gomez J.-L.   Cusan L.   Labrie F.  

Urology, Vol. 53, Iss. 3, 1999-03 ,pp. : 523-529

Elsevier

Access to resources Recommend Favorite

Combined androgen blockade for the treatment of metastatic cancer of the prostate

By Schellhammer P.F.  

Urology, Vol. 47, Iss. 5, 1996-05 ,pp. : 622-628

Elsevier

Access to resources Recommend Favorite

Localised Prostate Cancer: Important Points of Conduct for Radical Retropubic Prostatectomy

By Myers R.P.  

European Urology Supplements, Vol. 1, Iss. 7, 2002-10 ,pp. : 15-19

Elsevier

Access to resources Recommend Favorite

Substratification of high-risk localised prostate cancer treated by radical prostatectomy

By Lodde Michele   Harel François   Lacombe Louis   Fradet Yves  

World Journal of Urology, Vol. 26, Iss. 3, 2008-06 ,pp. : 225-229

Springer Publishing Company

Access to resources Recommend Favorite

Radical prostatectomy for node-positive prostate cancer: Role of adjuvant radiotherapy

By Da Pozzo L.F.   Cozzarini C.   Bertini R.   Colombo R.   Mazzoccoli B.   Bolognesi A.   Villa E.   Rigatti P.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 39-39

Elsevier

Access to resources Recommend Favorite